ACR Gears Up For Key State Legislative Issues Including AI
ACR joined physician leaders at the AMA summit to address Medicaid, payer issues, physician-led care, wellness, and emerging AI legislation in states.
Read more
President Trump signed the Full-Year Continuing Appropriations and Extensions Act of 2025 March 15, keeping the government open through Sept. 30, the end of the federal fiscal year (FY). The act stopped a scheduled government shutdown and funds non-defense federal agencies and programs at approximately FY 2024 levels.
The law extends statutory language preventing the administration from imposing a 15% cap on Facilities and Administrative (F&A) cost reimbursement. The American College of Radiology® (ACR®) previously reported the intent of the National Institutes of Health (NIH) to cut research F&A reimbursement; however, a temporary restraining order was put in place to halt implementation of the cuts as there are multiple lawsuits pending in the courts..
ACR joined a coalition letter urging prioritization of robust NIH funding in lawmakers’ federal FY 2025 appropriations bill and preservation of existing protections against cuts to reimbursements for NIH grantee F&A costs. NIH funding encompasses support for radiology research, which includes a wide range of diagnostics, treatments and therapeutics that benefit patients and their families.
Congress nonetheless failed to include an increase to the Medicare Physician Fee Schedule (MPFS) conversion factor in this legislation. Therefore, the current MPFS conversion factor is approximately 2.8% below the 2024 conversion factor.
ACR will continue to work with our colleagues across the healthcare profession to include long-term Medicare payment reform in the government funding package expected later this year.
For more information or if you have questions, contact Katie Grady, ACR Government Affairs Director.
ACR Gears Up For Key State Legislative Issues Including AI
ACR joined physician leaders at the AMA summit to address Medicaid, payer issues, physician-led care, wellness, and emerging AI legislation in states.
Read more
FDA Updates Guidance on Clinical Decision Support
FDA’s 2026 CDS update clarifies which software is regulated, affirming oversight of image‑analysis tools while exempting certain guideline‑based CDS.
Read moreStates Begin to Introduce Bills for 2026
States launch 2026 sessions with new bills on AI governance, rural radiation therapy, imaging workforce standards, and dose rules.
Read more